We are live on ! Find out more

1,970 hedge funds and large institutions have $146B invested in Pfizer in 2015 Q4 according to their latest regulatory filings, with 195 funds opening new positions, 801 increasing their positions, 756 reducing their positions, and 80 closing their positions.

New
Increased
Maintained
Reduced
Closed

144% more first-time investments, than exits

New positions opened: 195 | Existing positions closed: 80

5% more funds holding

Funds holding: 1,8801,970 (+90)

1.41% more ownership

Funds ownership: 75.71%77.11% (+1.4%)

6% more repeat investments, than reductions

Existing positions increased: 801 | Existing positions reduced: 756

4% more capital invested

Capital invested by funds: $140B → $146B (+$6.18B)

5% less funds holding in top 10

Funds holding in top 10: 267253 (-14)

39% less call options, than puts

Call options by funds: $1.79B | Put options by funds: $2.95B

Holders
1,970
Holders Change
+90
Holders Change %
+4.79%
% of All Funds
51.67%
Holding in Top 10
253
Holding in Top 10 Change
-14
Holding in Top 10 Change %
-5.24%
% of All Funds
6.64%
New
195
Increased
801
Reduced
756
Closed
80
Calls
$1.79B
Puts
$2.95B
Net Calls
-$1.16B
Net Calls Change
-$1.83B
Name Holding Trade Value Shares
Change
Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$11.9B +$275M +8,742,720 +2%
State Street
2
State Street
Massachusetts
$10.1B +$4.31M +136,860 +0%
BIT
3
BlackRock Institutional Trust
California
$5.33B +$74.3M +2,360,828 +1%
JP Morgan Chase
4
JP Morgan Chase
New York
$3.84B +$249M +7,928,216 +7%
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$3.63B +$257M +8,172,114 +7%
BFA
6
BlackRock Fund Advisors
California
$2.94B +$188M +5,979,870 +7%
Capital World Investors
7
Capital World Investors
California
$2.88B -$1.47B -46,610,832 -33%
Bank of New York Mellon
8
Bank of New York Mellon
New York
$2.86B -$378M -12,012,288 -11%
Northern Trust
9
Northern Trust
Illinois
$2.67B -$186M -5,919,547 -6%
Bank of America
10
Bank of America
North Carolina
$2.57B +$81.8M +2,600,126 +3%
Wellington Management Group
11
Wellington Management Group
Massachusetts
$2.55B -$99.9M -3,175,019 -4%
Ameriprise
12
Ameriprise
Minnesota
$1.97B +$230M +7,324,102 +13%
State Farm Mutual Automobile Insurance
13
State Farm Mutual Automobile Insurance
Illinois
$1.93B
Norges Bank
14
Norges Bank
Norway
$1.82B +$128M +4,081,346 +7%
BG
15
BlackRock Group
United Kingdom
$1.82B -$31.1M -988,922 -2%
AllianceBernstein
16
AllianceBernstein
Tennessee
$1.79B +$445M +14,131,242 +32%
Deutsche Bank
17
Deutsche Bank
Germany
$1.74B +$604M +19,194,969 +51%
Franklin Resources
18
Franklin Resources
California
$1.74B -$695M -22,096,699 -28%
Barrow, Hanley, Mewhinney & Strauss
19
Barrow, Hanley, Mewhinney & Strauss
Texas
$1.74B -$13.6M -433,675 -0.8%
Massachusetts Financial Services
20
Massachusetts Financial Services
Massachusetts
$1.7B -$103M -3,275,325 -6%
Goldman Sachs
21
Goldman Sachs
New York
$1.68B +$422M +13,413,715 +32%
Geode Capital Management
22
Geode Capital Management
Massachusetts
$1.65B -$10.3M -327,690 -0.6%
Dimensional Fund Advisors
23
Dimensional Fund Advisors
Texas
$1.4B -$44.7M -1,420,849 -3%
BA
24
BlackRock Advisors
Delaware
$1.36B +$16.6M +529,167 +1%
Invesco
25
Invesco
Georgia
$1.26B -$200M -6,348,479 -13%

PFE Hedge Fund Activity: Q4 2015 in Review

1,970 of the 3,813 institutional investors tracked by Wall St. Rank reported a position in Pfizer (PFE) for Q4 2015, worth a combined $146B — up 4.4% from $140B a quarter earlier.

Buyers outnumbered sellers: 195 funds opened new PFE positions and 80 closed out — a net gain of 115 holders — while 801 added to existing stakes and 756 trimmed.

The largest buyer was Deutsche Bank, adding an estimated $604M. The largest seller was Capital World Investors, cutting an estimated $1.47B.

  • 1,970 institutional investors held Pfizer (PFE) as of Q4 2015, up from 1,880 in Q3 2015.
  • Funds reported $146B of Pfizer stock for Q4 2015, up 4.4% quarter-over-quarter.
  • 195 funds opened new Pfizer positions in Q4 2015 and 80 closed out, a net change of +115 holders.
  • The largest Pfizer buyer in Q4 2015 was Deutsche Bank, an estimated $604M added.
  • The largest Pfizer seller in Q4 2015 was Capital World Investors, an estimated $1.47B sold.

Based on aggregated 13F filings for Q4 2015.